08:00 , Dec 15, 2014 |  BC Week In Review  |  Company News

Corticrine, Actinogen deal

Actinogen acquired Corticrine, a spinout of Edinburgh BioQuarter, the commercialization arm of the College of Medicine and Veterinary Medicine of the University of Edinburgh . Under the agreement, Actinogen issued 125 million shares and raised...